期刊文献+

球囊扩张术后观察阿托伐他汀对颈内动脉动脉粥样硬化斑块的影响 被引量:1

The clinical effects of atorvastatin on arteria carotis atherosclerotic plaque after balloon dilation
下载PDF
导出
摘要 目的观察阿托伐他汀对稳定颈内动脉粥样硬化斑块的临床疗效。方法选择64例颈内动脉粥样硬化斑块形成并致颈内动脉起始处严重狭窄(狭窄率>70%,<90%)而接受狭窄段球囊扩张加支架置入的患者。将患者分为两组,治疗组34例,治疗前服用阿托伐他汀20 mg,1次/晚,至少3个月;对照组30例,未服用他汀类药物。于球囊扩张狭窄段治疗后取出保护伞。观察保护伞内有无脱落的粥样物质。结果治疗组收集到的粥样物质人数较对照组明显少,且差异有统计学意义(P<0.01)。结论阿托伐他汀可以使颈内动脉粥样硬化斑块稳定,可作为治疗颈内动脉粥样硬化的常规用药。 Objective To examine the clinical effects of atorvastatin on arteria carotis atherosclerotic plaque.Methods 64 patients with carotid artery atherosclerotic plaque formation and caused the beginning of severe carotid artery stenosis(stenosis rate 70%,90%) accept the stricture balloon dilatation and stent implantation in patients were chosen.The patients were divided into 2 groups,treatment group with 34 patients taking atorvastatin 20mg,1 times/night,for at least 3 months before treatment control group with 30 patients not taking statins.In the treatment of stenosis after balloon out umbrella,observed and whether the umbrella off the porridge-like substance.Results The treatment group collected the number of atherosclerotic material and significantly less than the control group,the difference was significant(P 0.01).Conclusion Atorvastatin can make the arteria carotis stability,and can be used as treatment of carotid atherosclerosis in conventional medicine.
出处 《安徽医学》 2011年第6期778-779,共2页 Anhui Medical Journal
关键词 阿托伐他汀 颈内动脉粥样硬化斑块 球囊扩张 保护伞 Atorvastatin Carotid artery atherosclerosis Balloon dilation Umbrella
  • 相关文献

参考文献10

  • 1潘升权,万圣云,汪凯,丁洋,张同方.颅外颈动脉狭窄诊断及治疗进展[J].安徽医学,2009,30(2):145-147. 被引量:10
  • 2Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of in- tensive compared with moderate lipid -lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA,2004, 291(9) : 1071 - 1080.
  • 3赵春水.颈动脉粥样硬化与脑梗死相关性研究[J].中国实用神经疾病杂志,2009,12(24):15-17. 被引量:26
  • 4贾伟华,田桂玲.颈动脉斑块稳定性的研究进展[J].国外医学(脑血管疾病分册),2004,12(2):145-148. 被引量:61
  • 5Michael B. Clearfield. Altering the Pathophysiology of Ath- erosclerosis: the multidimensional role of statins. JAOA , 2010,110(4) : 2 -6.
  • 6Inoue T, Node K. Statin therapy for vascular failure. Card- iovasc Dings Ther, 2007, 21(4): 281 -295.
  • 7Zhou Q, Liao JK. Statins and cardiovascular diseases from cholesterol lowering to pleiotropy. Curr Pharm Dis, 2009, 15 (5) :467 -478.
  • 8Deng JW, Kim KB,Song IS, et al. Determination of two HMG -CoA reductase inhibitors, pravastatin and pitavastatin, in plasma samples using liquid chromatography - tandem mass spectrometry for pharmaceutical study. Biomed Chromatogr, 2008,22(2) : 131 - 135.
  • 9Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated c -reactive protein. N Engl J Med,2008, 359(21 ) : 2195 - 2207.
  • 10Ge C J, Lu SZ, Chen YD,et al. Synergistic effect offect of am- lodipine and atorvastin therapy on endothelial function in pa- tients with coronary artery disease. Heart Vessels, 2005,23 (2) ,91 -93.

二级参考文献57

共引文献94

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部